JPY7,979.00
1.41% today
Tokyo, Sep 19, 02:40 am CET
ISIN
JP3188220002
Symbol
4578
Index
Sector
Industry

Otsuka Stock price

JPY7,868.00
-282.00 3.46% 1M
+1,544.00 24.41% 6M
+2,579.00 48.76% YTD
+2,322.00 41.87% 1Y
+2,977.00 60.87% 3Y
+3,154.00 66.91% 5Y
+4,216.00 115.44% 10Y
Tokyo, Closing price Wed, Sep 18 2024
-176.00 2.19%
ISIN
JP3188220002
Symbol
4578
Index
Sector
Industry

Key metrics

Market capitalization JPY4.27t
Enterprise Value JPY4.08t
P/E (TTM) P/E ratio 33.67
EV/FCF (TTM) EV/FCF 19.67
EV/Sales (TTM) EV/Sales 1.87
P/S ratio (TTM) P/S ratio 1.96
P/B ratio (TTM) P/B ratio 1.63
Dividend yield 1.49%
Last dividend (FY24) JPY120.00
Revenue growth (TTM) Revenue growth 16.50%
Revenue (TTM) Revenue JPY2.18t
EBIT (operating result TTM) EBIT JPY341.95b
Free Cash Flow (TTM) Free Cash Flow JPY207.31b
Cash position JPY485.89b
EPS (TTM) EPS JPY233.68
P/E forward 19.23
P/S forward 1.91
EV/Sales forward 1.82
Show more

Is Otsuka a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.

Otsuka Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Otsuka forecast:

7x Buy
70%
3x Hold
30%

Analyst Opinions

10 Analysts have issued a Otsuka forecast:

Buy
70%
Hold
30%

Financial data from Otsuka

Dec '23
+/-
%
Net Profit 121,616 121,616
9% 9%
6%
Depreciation and Amortization 97,777 97,777
4% 4%
5%
Stock Compensation - -
-
-
Operating Cash Flow 283,232 283,232
34% 34%
14%
Investments 114,673 114,673
6% 6%
6%
Dividend Paid 55,653 55,653
0% 0%
3%
Free Cash Flow 192,496 192,496
28% 28%
10%

In millions JPY.

Don't miss a Thing! We will send you all news about Otsuka directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Otsuka Holdings Co., Ltd. engages in the manufacture and sale of pharmaceuticals and nutritional supplements. It operates through the following business segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals segment manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. The Nutraceuticals segment develops and markets nutrition products such as nutritional food, quasi-drugs, health drinks, and dietary supplements for homes, medical facilities, and nursing care units. The Consumer Products segment sells mineral water, food, and beverages. Its products include Bon Curry, Mannan Hikari, and ReSOLA. The Others segment distributes functional and fine chemicals, optical inspection devices, and clinical diagnosis equipment. The company was founded in1950 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Tatsuo Higuchi
Employees 34,388
Founded 1921
Website www.otsuka.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today